Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that certain mutations may contribute to the inflammation in hidradenitis suppurativa and suggests that targeting TNFα could be a treatment strategy.

Finasteride caused a rare skin rash in a man, which improved after stopping the medication.

CRTH2 antagonists might be useful for treating many conditions because they play a role in immune and inflammation responses.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

Changthangi goats have specific genes that help produce Pashmina wool.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

Chemotherapy can cause brain inflammation and damage, and understanding this process could help manage side effects.

Some diseases can improve the outcomes of other diseases, leading to new treatment possibilities.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

The document concludes that computational models are useful for understanding immune responses and could improve cancer immunotherapy.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

TGPC plus CGT is effective and safe for treating severe alopecia areata in children.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

New psoriasis treatments are effective but come with side effects and risks.

Lupus panniculitis of the scalp causes linear hair loss and needs ongoing treatment to prevent recurrence and lupus.

Hair follicle stem cells are promising for wound healing but require more research for safe clinical use.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

A patient with Satoyoshi syndrome improved with a treatment combining several medications, including carbamazepine and methotrexate.

A specific DNA region is crucial for Foxn1 gene expression in thymus cells but not in hair follicles.

A rare genetic mutation found in an Indian family can be detected through prenatal screening.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.